InvestorsHub Logo
Followers 78
Posts 4365
Boards Moderated 0
Alias Born 09/26/2009

Re: newtechinvestor post# 79

Sunday, 12/20/2009 3:34:27 PM

Sunday, December 20, 2009 3:34:27 PM

Post# of 20775
"but it worked better in people without a genetic marker, ApoE e4, linked to Alzheimer’s."

And from what I remember about how they set up the Phase III, it will be quite favorable to show results for people w/wo the ApoE
Which should lead to an approval for bapineuzumab in the population that it is most effective for.
I believe in bapineuzumab and had bought ELN after the results from the phase II and Tysabri had taken it down in the Summer of 08. I traded in and out of ELN, but when doing more DD I discovered ILNS. I don't know how much royalty payments will be, but I've had GREAT "luck" with a biotech in the past that had something similar. That biotech is TTNP. ILNS and TTNP are the only stocks I'm SUPER LONG in. I'm up over 6,000% in my TTNP and about even on my ILNS. I'm looking towards 2012 for ILNS to reach it's potiential. I believe in bapineuzumab and I'd say it looks like JNJ and PFE believe in it too. :)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.